Records containing: Solid Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-09-30A Phase Ib, Open-Label, Multicenter Study of the Safety and Pharmacokinetics of the Combination of RhuMab 2C4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-09-23A Phase I Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2015-08-27Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
-
CLINICAL_TRIALS study record update · 2015-08-24A Phase Ib/ii, Multicenter, Trial Of Cvx-060, A Selective Angiopoietin-2 (Ang-2) Binding, Anti-angiogenic Covx-body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2015-07-14Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-07-08Open Label, Dose Escalation Trial of Oral PXD101 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-06-04The Good Patient Study
-
CLINICAL_TRIALS study record update · 2015-05-18Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence: A Multi-Institutional Study
-
CLINICAL_TRIALS study record update · 2015-04-23A Phase I Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Cancer
-
CLINICAL_TRIALS study record update · 2015-03-10A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients With Malignancies Expressing NY-ESO-1
-
CLINICAL_TRIALS study record update · 2015-02-18An Open-Label, Multicentre Trial to Evaluate the Time Associated With the Preparation and Administration of Denosumab and Pamidronate in Subjects With Solid Tumors and Metastatic Bone Disease in Canada
-
CLINICAL_TRIALS study record update · 2015-02-13A Phase I Trial of Oral Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, in Combination With Bevacizumab for Patients With Advanced Cancers
-
CLINICAL_TRIALS study record update · 2015-02-10A Phase I Dose Escalation Study Evaluating MK-8109 (Vintafolide) in Japanese Subjects With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2014-12-17A Phase I/II Study to Evaluate the Efficacy and Toxicity of Imatinib Mesylate in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2014-12-11Pilot Study of Early Enteral Tube Feedings in Children Receiving Chemotherapy for Newly Diagnosed AML/MDS and High Risk Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-10-02ClinicalTrials.gov study NCT02255292
-
CLINICAL_TRIALS study record update · 2014-09-19An Open-label, Dose Escalation, Safety and Pharmacokinetics Phase 1 Study With AVE8062 Administered as a 30-minute Intravenous Infusion Every 3 Weeks in Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2014-07-16A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-06-18A Study to Evaluate the Relationship Between Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2014-06-11A Phase I, Non-randomized, Open-label, Repeat Oral Administration Study of ASP3026 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-03-11A Phase I Open-Label, Ascending Dose Cohort Study of Gemcitabine Elaidate and Cisplatin in Patients With Advanced Solid Tumors Followed by an Expanded Cohort of Patients With Stage IIIb/IV NSCLC.
-
CLINICAL_TRIALS study record update · 2014-02-25A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-14A Phase I Study of E7050 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-29A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-01-23A Single-Blind, Multicenter, Placebo-Controlled, Sequential Design Study Evaluating the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram